SNY Sanofi
Stable Earnings Power
B- 62.1 / 100 composite

AlphaQuality composite grade, weighted for stable earnings power businesses.

Profitability

Weight: 20%
D 38
  • 5yr Avg ROIC 7.0%
  • Operating Margin Trend -0.91 pp/yr

Capital Efficiency

Weight: 15%
C+ 62
  • 5yr Avg ROE 9.1%
  • 5yr Share-Count CAGR -0.5%

Growth Quality

Weight: 15%
C- 47
  • 5yr Revenue CAGR 4.6%
  • 5yr EPS CAGR -8.2%
  • Revenue-Growth Years (5) 5/5

Cash Generation

Weight: 15%
A 92
  • 5yr FCF Margin 19.0%
  • 5yr FCF/NI Conversion 1.22x

Balance Sheet

Weight: 20%
B 71
  • Net Debt / EBITDA 0.95x
  • Interest Coverage (EBIT/Int) 10.86x
  • Altman Z-Score 1.53

Stability

Weight: 15%
B- 67
  • EPS Volatility (σ/μ) 0.42
  • Negative-Revenue Years (5) 0/5
  • Piotroski F-Score 7

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

2 of 2 gurus held; 1 new buy; 1 added.

Holders
2 +2
Avg Δ position
New buys
1
Full exits
0
As of Q2 2026